New Brunswick, NJ, United States of America

Darren R Carpizo

USPTO Granted Patents = 7 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Darren R Carpizo

Introduction

Darren R Carpizo is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in developing compounds and therapeutic methods for treating cancer. With a total of 7 patents to his name, Carpizo's work has the potential to impact the medical community profoundly.

Latest Patents

Among his latest patents, Carpizo has developed pharmaceutical compounds that provide a complex comprising Zn and a compound of formula (I), or a deuterated analog thereof, or an ion or poly-ion thereof, or a salt thereof. These inventions are particularly useful for treating cancer and include compositions and kits that utilize such complexes. Another patent focuses on a similar complex comprising Zn2+, further emphasizing his commitment to advancing cancer treatment methodologies.

Career Highlights

Throughout his career, Carpizo has worked with prestigious institutions such as Rutgers, the State University of New Jersey, and the State University of New York. His experience in these academic environments has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include John A Gilleran and Spencer David Kimball. Their collaborative efforts have likely enhanced the quality and impact of Carpizo's inventions.

Conclusion

Darren R Carpizo's innovative work in pharmaceutical compounds showcases his dedication to improving cancer treatment options. His patents reflect a commitment to advancing medical science and highlight the importance of collaboration in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…